Halozyme Therapeutics (HALO)
NASDAQ:HALO

Halozyme (HALO) Technical Analysis

840 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
4Neutral
4Bearish
Technical Analysis Consensus
Sell
2Bullish
4Neutral
4Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Halozyme Therapeutics’s (HALO) Moving Averages Convergence Divergence (MACD) indicator is 1.60, suggesting Halozyme Therapeutics is a Sell.
Halozyme Therapeutics’s (HALO) 20-Day exponential moving average is 53.40, while Halozyme Therapeutics’s (HALO) share price is $56.23, making it a Buy.
Halozyme Therapeutics’s (HALO) 50-Day exponential moving average is 50.12, while Halozyme Therapeutics’s (HALO) share price is $56.23, making it a Buy.

Halozyme (HALO) Pivot Points

Jul 27, 2024, 05:20 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
53.43
53.99
54.57
55.12
55.70
56.26
56.84
Fibonacci
53.99
54.42
54.69
55.12
55.56
55.82
56.26
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Halozyme (HALO) Moving Averages

Jul 27, 2024, 05:20 AM
Period
Simple
Exponential
MA5
54.98Buy
55.16Buy
MA10
54.48Buy
54.53Buy
MA20
53.34Buy
53.40Buy
MA50
49.80Buy
50.12Buy
MA100
45.03Buy
46.55Buy
MA200
40.99Buy
43.33Buy
Halozyme Therapeutics’s (HALO) 10-Day exponential moving average is 54.53, while Halozyme Therapeutics’s (HALO) share price is $56.23, making it a Buy.
Halozyme Therapeutics’s (HALO) 100-Day exponential moving average is 46.55, while Halozyme Therapeutics’s (HALO) share price is $56.23, making it a Buy.
Halozyme Therapeutics’s (HALO) stock price is $56.23 and Halozyme Therapeutics’s (HALO) 50-day simple moving average is 49.80, creating a Buy signal.
Halozyme Therapeutics’s (HALO) stock price is $56.23 and Halozyme Therapeutics’s (HALO) 100-day simple moving average is 45.03, creating a Buy signal.
Halozyme Therapeutics’s (HALO) stock price is $56.23 and Halozyme Therapeutics’s (HALO) 200-day simple moving average is 40.99, creating a Buy signal.

Halozyme (HALO) Technical Indicators

Jul 27, 2024, 05:20 AM
Name
Value
Implied Action
RSI (14)
70.78
Sell
STOCH (9,6)
74.44
Neutral
STOCHRSI (14)
78.46
Neutral
MACD (12,26)
1.60
Sell
ADX (14)
42.22
Neutral
Williams %R
-18.48
Sell
CCI (14)
160.01
Sell
ATR (14)
1.54
-
Ultimate Oscillator
49.24
Neutral
ROC
8.55
Buy
Halozyme Therapeutics’s (HALO) Relative Strength Index (RSI) is 70.78, creating a Sell signal.
Halozyme Therapeutics’s (HALO) Trend Strength Indicator (ADX) is 42.22, creating a Neutral signal.
Halozyme Therapeutics’s (HALO) Commodity Channel Index (CCI) is 160.01, creating a Sell signal.
Halozyme Therapeutics’s (HALO) Price Rate of Change (ROC) is 8.55, creating a Buy signal.

FAQ

Is HALO a Buy, Hold, or Sell?
Based on HALO’s technical indicators, HALO is a Buy.
    What is HALO’s RSI (14)?
    HALO’s RSI (14) is 70.78, which suggests HALO is a Sell.
      What is HALO’s MACD?
      HALO’s MACD is 1.60, which suggests HALO is a Sell.
        What is HALO’s 5-day moving average?
        HALO’s 5-day moving average is 54.98, which suggests HALO is a Buy.
          What is HALO’s 20-day moving average?
          HALO 20-day moving average is 53.34, which suggests HALO is a Buy.
            What is HALO’s 50-day moving average?
            HALO’s 50-day moving average is 49.80, which suggests HALO is a Buy.
              What is HALO’s 200-day moving average?
              HALO’s 200-day moving average is 40.99, which suggests HALO is a Buy.
                What is HALO’s Williams % R (14)?
                HALO’s Williams % R (14) is -18.48, which suggests HALO is a Sell.
                  What is HALO’s CCI (14)?
                  HALO’s CCI (14) is 160.01, which suggests HALO is a Sell.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis